KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Tax Rate (2017 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Tax Rate for 9 consecutive years, with 487.5% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate fell 47576.0% year-over-year to 487.5%, compared with a TTM value of 17.83% through Dec 2025, up 3482.0%, and an annual FY2025 reading of 14.72%, up 3793.0% over the prior year.
  • Tax Rate was 487.5% for Q4 2025 at Teva Pharmaceutical Industries, down from 25.17% in the prior quarter.
  • Across five years, Tax Rate topped out at 77.59% in Q2 2022 and bottomed at 487.5% in Q4 2025.
  • Average Tax Rate over 5 years is 27.99%, with a median of 7.83% recorded in 2023.
  • The sharpest move saw Tax Rate soared 4566bps in 2022, then tumbled -47576bps in 2025.
  • Year by year, Tax Rate stood at 13.71% in 2021, then crashed by -192bps to 12.57% in 2022, then skyrocketed by 169bps to 8.67% in 2023, then crashed by -235bps to 11.74% in 2024, then tumbled by -4052bps to 487.5% in 2025.
  • Business Quant data shows Tax Rate for TEVA at 487.5% in Q4 2025, 25.17% in Q1 2025, and 11.74% in Q4 2024.